Vision
To deliver comprehensive drug development services and to establish Bangladesh as a globally recognized, reliable and cost-effective destination for end to end management of clinically-viable clinical trials.

Clinical Research Organization
crobangladesh@gmail.com
+8801819251514
About Us
Clinical Research Organization Limited (CRO Ltd.) is a pioneer Bangladeshi private contract research organization providing clinical and non-clinical research services to the pharmaceutical and biotechnology industries.
CRO Ltd. was approved by the Directorate General of Drug Administration (DGDA), the Drug Regulatory Authority of Bangladesh in 2016 as the 2nd contract research organization of the country. In 2021 CRO Ltd. was also approved by the DGDA to conduct trial of veterinary vaccines and medicines as first CRO in the country.
It has capabilities for conducting phase I-III clinical trials, including those using antiviral drugs, anti-inflammatory drugs, anti-cancers drugs and immune modulators, across different Specialties of Medical Science. CRO Ltd. has been involved in more than 10 clinical trials, all of which have been carried out under regulatory supervision.
Vision
To deliver comprehensive drug development services and to establish Bangladesh as a globally recognized, reliable and cost-effective destination for end to end management of clinically-viable clinical trials.
Quality Policy
CRO Ltd. is committed to
Key Advantages
CRO Ltd. conforms to standards of clinical research as per guide-lines laid down by regulatory body
Managed by a group of dedicated professionals with experience in clinical research.
Experienced in Phase I-III clinical trials
Clinical trial site in Dhaka city for clinical trials.
With a base of qualified investigators.
Collectively the Investigators have over 700 scientific publications in peer reviewed journals and more than 1000 scientific conference talks to their credit.
Equipment standardized in accordance with SOPs and regulatory requirements.
Database of healthy volunteers.
Accreditations
Institutional Review Board
CRO Ltd.’s IRB is approved by Directorate General of Drug Administration.